Literature DB >> 15033936

Aberrant gating, but a normal expression pattern, underlies the recessive phenotype of the deafness mutant Connexin26M34T.

I M Skerrett1, W-L Di, E M Kasperek, D P Kelsell, B J Nicholson.   

Abstract

Mutations in the gene GJB2, encoding the gap junction protein Connexin26 (Cx26), are the most prevalent cause of inherited hearing loss, and Cx26M34T was one of the first mutations linked to deafness (Kelsell et al., 1997; Nature 387, 80-83). We report the first characterization of the gating properties of M34T, which had previously been reported to be nonfunctional. Although homotypic mutant channels did not produce detectable currents, heterotypic pairings with wtCx26 confirmed that M34T formed intercellular channels, although the gating properties were altered. Cx26M34T displayed an inverted response to transjunctional voltage (Vj), mediating currents that activate in a time- and Vj-dependent manner. These characteristics suggest that the channel population is only partially open at rest, consistent with previous reports that dye transfer in M34T-expressing cells is reduced or abolished (e.g., Thonnissen et al., Human Genet. 111, 190-197). To investigate the controversial recessive/dominant behavior of this mutant, we coexpressed M34T with wtCx26 RNA at equimolar levels, mimicking the situation in heterozygotic individuals. Under these conditions, M34T did not significantly reduce Cx26/Cx26 coupling, or alter the electrophysiological properties of the wt channels, consistent with the recessive nature of the allele. Overexpression of the mutant did have some inhibitory effects on conductance, possibly explaining some of the previous reports in exogenous expression systems and some patients. Consistent with its electrophysiological behavior, we also show that M34T localizes to cell junctions in both transfected HeLa cells and patient-derived tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033936     DOI: 10.1096/fj.03-0763fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Asymmetric configurations and N-terminal rearrangements in connexin26 gap junction channels.

Authors:  Atsunori Oshima; Kazutoshi Tani; Masoud M Toloue; Yoko Hiroaki; Amy Smock; Sayaka Inukai; Angela Cone; Bruce J Nicholson; Gina E Sosinsky; Yoshinori Fujiyoshi
Journal:  J Mol Biol       Date:  2010-11-20       Impact factor: 5.469

2.  Analysis of four connexin26 mutant gap junctions and hemichannels reveals variations in hexamer stability.

Authors:  Cinzia Ambrosi; Daniela Boassa; Jennifer Pranskevich; Amy Smock; Atsunori Oshima; Ji Xu; Bruce J Nicholson; Gina E Sosinsky
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

3.  Tryptophan Scanning Reveals Dense Packing of Connexin Transmembrane Domains in Gap Junction Channels Composed of Connexin32.

Authors:  Matthew J Brennan; Jennifer Karcz; Nicholas R Vaughn; Yvonne Woolwine-Cunningham; Adam D DePriest; Yerko Escalona; Tomas Perez-Acle; I Martha Skerrett
Journal:  J Biol Chem       Date:  2015-05-12       Impact factor: 5.157

4.  GJB2 mutations and degree of hearing loss: a multicenter study.

Authors:  Rikkert L Snoeckx; Patrick L M Huygen; Delphine Feldmann; Sandrine Marlin; Françoise Denoyelle; Jaroslaw Waligora; Malgorzata Mueller-Malesinska; Agneszka Pollak; Rafal Ploski; Alessandra Murgia; Eva Orzan; Pierangela Castorina; Umberto Ambrosetti; Ewa Nowakowska-Szyrwinska; Jerzy Bal; Wojciech Wiszniewski; Andreas R Janecke; Doris Nekahm-Heis; Pavel Seeman; Olga Bendova; Margaret A Kenna; Anna Frangulov; Heidi L Rehm; Mustafa Tekin; Armagan Incesulu; Hans-Henrik M Dahl; Desirée du Sart; Lucy Jenkins; Deirdre Lucas; Maria Bitner-Glindzicz; Karen B Avraham; Zippora Brownstein; Ignacio del Castillo; Felipe Moreno; Nikolaus Blin; Markus Pfister; Istvan Sziklai; Timea Toth; Philip M Kelley; Edward S Cohn; Lionel Van Maldergem; Pascale Hilbert; Anne-Françoise Roux; Michel Mondain; Lies H Hoefsloot; Cor W R J Cremers; Tuija Löppönen; Heikki Löppönen; Agnete Parving; Karen Gronskov; Iris Schrijver; Joseph Roberson; Francesca Gualandi; Alessandro Martini; Geneviéve Lina-Granade; Nathalie Pallares-Ruiz; Céu Correia; Graça Fialho; Kim Cryns; Nele Hilgert; Paul Van de Heyning; Carla J Nishimura; Richard J H Smith; Guy Van Camp
Journal:  Am J Hum Genet       Date:  2005-10-19       Impact factor: 11.025

5.  Asymmetric expression of connexins between luminal epithelial- and myoepithelial- cells is essential for contractile function of the mammary gland.

Authors:  Rana Mroue; Jamie Inman; Joni Mott; Irina Budunova; Mina J Bissell
Journal:  Dev Biol       Date:  2014-12-11       Impact factor: 3.582

Review 6.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

7.  The M34A mutant of Connexin26 reveals active conductance states in pore-suspending membranes.

Authors:  Oliver Gassmann; Mohamed Kreir; Cinzia Ambrosi; Jennifer Pranskevich; Atsunori Oshima; Christian Röling; Gina Sosinsky; Niels Fertig; Claudia Steinem
Journal:  J Struct Biol       Date:  2009-02-21       Impact factor: 2.867

8.  Connexin26 deafness associated mutations show altered permeability to large cationic molecules.

Authors:  Gülistan Meşe; Virginijus Valiunas; Peter R Brink; Thomas W White
Journal:  Am J Physiol Cell Physiol       Date:  2008-08-06       Impact factor: 4.249

Review 9.  Gap-junction channels dysfunction in deafness and hearing loss.

Authors:  Agustín D Martínez; Rodrigo Acuña; Vania Figueroa; Jaime Maripillan; Bruce Nicholson
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

10.  Properties of two cataract-associated mutations located in the NH2 terminus of connexin 46.

Authors:  Jun-Jie Tong; Bonnie C H Sohn; Anh Lam; D Eric Walters; Barbara M Vertel; Lisa Ebihara
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-09       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.